Spunti di Nutrizione rev2011 - Clinica Pediatrica Trieste - Università ...

Recommendations

Info

8. Bibliografia 64 Sblattero, D. et al. (2004) The gut as site of production of autoimmune antibodies. Journal of pediatric gastroenterology and nutrition 39 Suppl 3, S730-731 65 Koskinen, O. et al. (2008) Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease. Journal of pediatric gastroenterology and nutrition 47 (4), 436-442 66 Marzari, R. et al. (2001) Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 166 (6), 4170-4176 67 Maglio, M. et al. (2009) Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. Diabetes 58 (7), 1578-1584 68 Sblattero, D. et al. (2004) One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. Journal of autoimmunity 22 (1), 65-72 69 Crohn, B.B. et al. (1952) Regional ileitis; a pathologic and clinical entity. The American journal of medicine 13 (5), 583-590 70 Kiefer, E.D. and Arnold, W.T. (1950) Nutritional problems following resection of the small intestine for regional ileitis. Journal of the American Medical Association 144 (11), 903-909 71 Dyer, N.H. et al. (1972) Anaemia in Crohn's disease. The Quarterly journal of medicine 41 (164), 419-436 72 Machella, T.E. and Hollan, O.R. (1951) The effect of cortisone on the clinical course of chronic regional enteritis and chronic idiopathic ulcerative colitis. The American journal of the medical sciences 221 (5), 501-507 73 Goldstein, M.J. et al. (1967) Some observations on the hazards of corticosteroid therapy in patients with inflammatory bowel disease. Transactions - American Academy of Ophthalmology and Otolaryngology 71 (2), 254-261 74 Selzer, J.D. and Mc, C.R. (1958) The sigmoidoscopic diagnosis of regional enteritis. American journal of surgery 95 (1), 144-146 75 Bean, R.H. (1962) The treatment of chronic ulcerative colitis with 6mercaptopurine. The Medical journal of Australia 49(2), 592-593 76 Present, D.H. et al. (1980) Treatment of Crohn's disease with 6mercaptopurine. A long-term, randomized, double-blind study. The New England journal of medicine 302 (18), 981-987 77 Loftus, E.V., Jr. et al. (1998) Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 114 (6), 1161-1168 78 Oberhelman, H.A., Jr. et al. (1968) Diverting ileostomy in the surgical management of Crohn's disease of the colon. American journal of surgery 115 (2), 231-240 79 Stephens, R.V. and Randall, H.T. (1969) Use of concentrated, balanced, liquid elemental diet for nutritional management of catabolic states. Annals of surgery 170 (4), 642-668 148
149 8. Bibliografia 80 O'Morain, C. et al. (1980) Elemental diets in treatment of acute Crohn's disease. British medical journal 281 (6249), 1173-1175 81 Thomas, B.M. (1972) The double-contrast enema. Proceedings of the Royal Society of Medicine 65 (11), 964-965 82 Marks, G. and Moses, M.L. (1973) The clinical application of flexible fiberoptic colonoscopy. The Surgical clinics of North America 53 (3), 735-756 83 Smith, M.P. (1967) White blood cell count in regional enteritis. Report of two cases. Jama 201 (11), 890 84 Riis, P. and Anthonisen, P. (1971) The presence of inflammatory leucocytes in the rectal mucus of patients with regional ileitis. Scandinavian journal of gastroenterology 6 (8), 719-721 85 Kendall, M.J. (1973) Is the xylose test worthwhile? British medical journal 3 (5876), 405 86 MacGregor, G.A. (1970) Agent transmissible from Crohn's disease tissue. Lancet 2 (7667), 311 87 Bull, D.M. et al. (1971) Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease. The Journal of laboratory and clinical medicine 78 (5), 826 88 Bolton, P.M. et al. (1973) Is there impaired immunity in patients with Crohn's disease? The British journal of surgery 60 (4), 319 89 Main, J. et al. (1988) Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ (Clinical research ed 297 (6656), 1105-1106 90 Odeka, E.B. and Miller, V. (1997) Thalidomide in oral Crohn's disease refractory to conventional medical treatment. Journal of pediatric gastroenterology and nutrition 25 (2), 250-251 91 Sands, B.E. and Podolsky, D.K. (1999) New life in a sleeper: thalidomide and Crohn's disease. Gastroenterology 117 (6), 1485-1488 92 Targan, S.R. et al. (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. The New England journal of medicine 337 (15), 1029-1035 93 Ogura, Y. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (6837), 603-606 94 Hugot, J.P. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (6837), 599-603 95 Wilk, J.N. and Viney, J.L. (2002) GM-CSF treatment for Crohn's disease: a stimulating new therapy? Curr Opin Investig Drugs 3 (9), 1291-1296 96 Dieckgraefe, B.K. and Korzenik, J.R. (2002) Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 360 (9344), 1478-1480 97 Moss, A.C. and Farrell, R.J. (2005) Adding fuel to the fire: GM-CSF for active Crohn's disease. Gastroenterology 129 (6), 2115-2117
Page 1:
Spunti di Nutrizione Pediatrica per
Page 4 and 5:
Premessa Che cosa un pediatra può
Page 6 and 7:
Premessa ricordare che la cosiddett
Page 8 and 9:
Premessa Il docente Alberto Tommasi
Page 12 and 13:
1. Introduzione 2. Intestino e ambi
Page 14 and 15:
1.Introduzione Endocrinopatie autoi
Page 16 and 17:
1.Introduzione controllabili con le
Page 18 and 19:
1.Introduzione fertilità cui si ag
Page 20 and 21:
1.Introduzione Fig. 1.2. Stime dell
Page 22 and 23:
2. Intestino e ambiente 2. Intestin
Page 24 and 25:
2. Intestino e ambiente sistema imm
Page 26 and 27:
2. Intestino e ambiente patogeni de
Page 28 and 29:
2. Intestino e ambiente Per meglio
Page 30 and 31:
2. Intestino e ambiente completa di
Page 32 and 33:
2. Intestino e ambiente sopprimere
Page 34 and 35:
2. Intestino e ambiente La maturazi
Page 36 and 37:
2. Intestino e ambiente Fig. 2.3. R
Page 38 and 39:
3. l latte materno costituisce un a
Page 40 and 41:
3. l latte materno • In alcuni ne
Page 42 and 43:
3. l latte materno dell’ambiente
Page 44 and 45:
4. Le allergie alimentari compresa
Page 46 and 47:
4. Le allergie alimentari cambiamen
Page 48 and 49:
4. Le allergie alimentari L’ipote
Page 50 and 51:
4. Le allergie alimentari compromis
Page 52 and 53:
4. Le allergie alimentari specifich
Page 54 and 55:
4. Le allergie alimentari un’ecce
Page 56 and 57:
4. Le allergie alimentari Nelle for
Page 58 and 59:
4. Le allergie alimentari Va da sé
Page 60 and 61:
4. Le allergie alimentari accidenta
Page 62 and 63:
4. Le allergie alimentari tra bambi
Page 64 and 65:
4. Le allergie alimentari Di fatto
Page 66 and 67:
4. Le allergie alimentari batteria
Page 68 and 69:
5. La malattia celiaca 5. La malatt
Page 70 and 71:
5. La malattia celiaca e mais rispe
Page 72 and 73:
5. La malattia celiaca Era Anni Cli
Page 74 and 75:
5. La malattia celiaca tuttavia per
Page 76 and 77:
5. La malattia celiaca 74 di un sog
Page 78 and 79:
5. La malattia celiaca La coscienza
Page 80 and 81:
5. La malattia celiaca Schematicame
Page 82 and 83:
5. La malattia celiaca stati Uniti
Page 84 and 85:
5. La malattia celiaca H Ascher, K
Page 86 and 87:
5. La malattia celiaca L’era degl
Page 88 and 89:
5. La malattia celiaca L’era dell
Page 90 and 91:
5. La malattia celiaca separati per
Page 92 and 93:
5. La malattia celiaca antigene da
Page 94 and 95:
5. La malattia celiaca Innanzitutto
Page 96 and 97:
5. La malattia celiaca geneticament
Page 98 and 99:
5. La malattia celiaca L’era dell
Page 100 and 101: 5. La malattia celiaca Marzari et a
Page 102 and 103: 5. La malattia celiaca pari degli a
Page 104 and 105: 5. La malattia celiaca Koskinen O,
Page 106 and 107: 5. La malattia celiaca variabili pi
Page 108 and 109: 5. La malattia celiaca somministraz
Page 110 and 111: 5. La malattia celiaca 108 Cambiame
Page 112 and 113: 5. La malattia celiaca prende atto
Page 114 and 115: 5. La malattia celiaca La nascita d
Page 116 and 117: 5. La malattia celiaca esordio più
Page 118 and 119: 5. La malattia celiaca Dal cortison
Page 120 and 121: 5. La malattia celiaca Cortisone: m
Page 122 and 123: 5. La malattia celiaca - Immunitari
Page 124 and 125: 5. La malattia celiaca individuale
Page 126 and 127: 5. La malattia celiaca I farmaci bi
Page 128 and 129: 5. La malattia celiaca rischio che
Page 130 and 131: 5. La malattia celiaca Nella tabell
Page 132 and 133: 5. La malattia celiaca Fig. 6.4 Str
Page 134 and 135: 5. La malattia celiaca Il meccanism
Page 136 and 137: 5. La malattia celiaca un relativo
Page 138 and 139: 5. La malattia celiaca la malattia
Page 140 and 141: 5. La malattia celiaca diminuzione
Page 142 and 143: 8. Bibliografia 7. Abbreviazioni e
Page 144 and 145: 8. Bibliografia MALT: sistema immun
Page 146 and 147: 8. Bibliografia 8. Bibliografia 1 X
Page 148 and 149: 8. Bibliografia 34 Dicke, W.K. et a
Page 152 and 153: 8. Bibliografia 98 Marks, D.J. et a
Page 154: 8. Bibliografia 131 Ma, T.Y. (1997)
show all

Spunti di Nutrizione rev2011 - Clinica Pediatrica Trieste - Università ...

Create successful ePaper yourself

Delete template?

Save as template?